BioXcel Therapeutics, Inc. Common Stock (BTAI)

$1.12 +2.74%
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-08-07 ESTIMATED
search

BioXcel Therapeutics, Inc. Common Stock (BTAI) has reported earnings 20 times since Aug 10, 2021. The stock moves an average of ±11.12% the day after reporting, closing higher 35.0% of the time. Its largest post-earnings gain was +29.41% (Nov 10, 2022) and its largest decline was -41.4% (Aug 14, 2023). The next earnings report is predicted for 2026-08-07 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

20

Avg Abs. Movement

±11.12%

Positive %

35.0%

Negative %

65.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
May 15, 2026 ☀ PRE $1.16 $1.20 $1.15 18,966 -5.35% open_in_new
Mar 27, 2026 ☀ PRE $1.34 $1.34 $1.26 16,228 -7.35% open_in_new
Nov 12, 2025 ☀ PRE $1.75 $1.84 $1.71 18,561 -16.01% open_in_new
Aug 12, 2025 ☀ PRE $5.45 $8.05 $6.74 225,270 +5.48% open_in_new
May 12, 2025 ☀ PRE $1.45 $1.51 $1.49 4,926 -1.97% open_in_new
Mar 27, 2025 ☽ POST $2.17 $2.28 $2.28 1,226 -6.14% open_in_new
Nov 14, 2024 ☀ PRE $0.59 $0.59 $0.53 2,100 -13.84% open_in_new
Aug 06, 2024 ☀ PRE $1.00 $1.00 $1.00 7,189 +8.24% open_in_new
May 09, 2024 ☀ PRE $2.26 $2.40 $2.31 7,867 +8.73% open_in_new
Mar 12, 2024 ☀ PRE $3.19 $3.21 $2.77 20,850 -5.47% open_in_new
Nov 14, 2023 ☀ PRE $3.54 $4.24 $4.21 141,119 -23.36% open_in_new
Aug 14, 2023 ☀ PRE $4.91 $4.97 $4.33 199,711 -41.4% open_in_new
May 08, 2023 ☀ PRE $21.56 $26.68 $26.30 48,739 +13.61% open_in_new
Mar 09, 2023 ☀ PRE $27.29 $28.48 $24.51 34,819 -13.58% open_in_new
Nov 10, 2022 ☀ PRE $11.78 $15.00 $14.74 27,497 +29.41% open_in_new
Aug 09, 2022 ☀ PRE $16.08 $16.08 $15.37 17,919 -7.52% open_in_new
May 09, 2022 ☀ PRE $12.05 $12.40 $11.30 32,375 -10.03% open_in_new
Mar 10, 2022 ☀ PRE $18.83 $18.83 $18.08 16,311 -4.03% open_in_new
Nov 10, 2021 ☀ PRE $34.88 $36.27 $34.16 8,469 +0.8% open_in_new
Aug 10, 2021 ☀ PRE $24.84 $24.99 $24.95 10,801 +0% open_in_new
event

Earnings Count

20

Total earnings in dataset

trending_up

Avg Abs. Movement

±11.12%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
4 20260522 open_in_new SEC.gov
4 20260522 open_in_new SEC.gov
4 20260522 open_in_new SEC.gov
4 20260522 open_in_new SEC.gov
144 20260520 open_in_new SEC.gov
144 20260520 open_in_new SEC.gov
144 20260520 open_in_new SEC.gov
144 20260520 open_in_new SEC.gov
10-Q 20260515 open_in_new SEC.gov
8-K 20260515 open_in_new SEC.gov

Frequently asked about BTAI earnings

When does BioXcel Therapeutics, Inc. Common Stock report earnings next? expand_more

BioXcel Therapeutics, Inc. Common Stock (BTAI)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does BTAI stock move after earnings? expand_more

Over 20 reports, BTAI has moved an average of ±11.12% the session after earnings, closing higher 35.0% of the time.

What was BTAI's biggest post-earnings move? expand_more

BTAI's largest post-earnings gain on record was +29.41% on Nov 10, 2022, and its largest decline was -41.4% on Aug 14, 2023.

Where can I find BioXcel Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of BioXcel Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers